Clinical trials
Phase 3 Alzheimer Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
| Active, not recruiting | 5 |
| Completed | 5 |
| Terminated | 5 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 6 |
| Eli Lilly and Company | 4 |
| Bristol-Myers Squibb | 2 |
| GlaxoSmithKline | 2 |
| JYAMS PET Research & Development Limited | 2 |
| APRINOIA Therapeutics | 1 |
| AriBio Co., Ltd. | 1 |
| AstraZeneca | 1 |
| Eisai Inc. | 1 |
| Eisai Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 29 |
| Cognitive Dysfunction | 5 |
| Dementia | 5 |
| Brain Diseases | 3 |
| Central Nervous System Diseases | 3 |
| Mental Disorders | 3 |
| Nervous System Diseases | 3 |
| Neurodegenerative Diseases | 3 |
| Tauopathies | 3 |
| Delirium | 2 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.